Prognostic significance of RelB overexpression in non‐small cell lung cancer patients

Lung cancer is a major public health issue in most countries, including China. The expression of RelB is associated with poor prognosis in diverse cancers. However, whether RelB expression could be an indicator of poor prognosis in non‐small cell lung cancer (NSCLC) is still unclear.

• Publication year

  2016

• Venue

  Thoracic Cancer

• Publication date

  2016-03-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1759-7714.12345PMID 27385983PMCID 4930960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin

  2015cited by this paper
• Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• [Effect of nuclear transcription factor RelB on the proteasome inhibitor-sensitivity of chronic lymphocytic leukemia cells].

  2014cited by this paper
• The incidences and mortalities of major cancers in China, 2010

  2014cited by this paper
• RelB regulates Bcl-xl expression and the irradiation-induced apoptosis of murine prostate cancer cells

  2014cited by this paper
• RelB: an outlier in leukocyte biology

  2013cited by this paper
• The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma

  2013cited by this paper
• Regulation of the Alternative NF-úb Pathway and Its Role in Cancer

  2013cited by this paper
• The incidence and mortality of major cancers in China, 2012

  2013cited by this paper
• NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation

  2012cited by this paper
• NF-κB, the first quarter-century: remarkable progress and outstanding questions.

  2012cited by this paper
• The RelB subunit of NFκB acts as a negative regulator of circadian gene expression

  2012cited by this paper
• Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival.

  2012cited by this paper
• NF‐κB and the link between inflammation and cancer

  2012cited by this paper
• The diverse and complex roles of NF-κB subunits in cancer

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Interpretation of Pathological Perspective——International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.

  2011cited by this paper
• Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation.

  2011cited by this paper
• Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.

  2010cited by this paper
• Inhibition of RelB by 1,25‐dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation

  2009cited by this paper
• Regulation and function of NF-kappaB transcription factors in the immune system.

  2009cited by this paper
• RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.

  2009cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumors

  2009cited by this paper
• [The alternative NF-kB activation pathway and cancer: friend or foe?].

  2008cited by this paper
• Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis.

  2008cited by this paper
• Voie alternative d’activation de NF-κB et cancer : Amis ou ennemis ?

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.

  2007cited by this paper
• Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism

  1986cited by this paper
• Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

  1986cited by this paper

• Dual-edged mechanisms of α-tomatine in hepatocellular carcinoma by suppression of Wnt/β-catenin signaling versus RelB-Driven resistance in tumor therapy

  2025cites this paper
• Gene expression alterations in hypoxic A549 lung cancer cell line

  2024cites this paper
• Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC

  2023cites this paper
• Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer

  2023cites this paper
• Human Papillomavirus in Non-Small Cell Lung Carcinoma: Assessing Virus Presence in Tumor and Normal Tissues and Its Clinical Relevance

  2023cites this paper
• Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks

  2022cites this paper
• Targeting NF-κB mediated cell signaling pathway and inflammatory mediators by 1,2-diazole in A549 cells in vitro

  2021cites this paper
• Pathway‐extended gene expression signatures integrate novel biomarkers that improve predictions of patient responses to kinase inhibitors

  2020cites this paper
• The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer

  2020cites this paper
• Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients

  2019cites this paper
• A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells

  2019cites this paper
• Differential impact of classical and non-canonical NF-κB pathway-related gene expression on the survival of breast cancer patients

  2019cites this paper
• Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma

  2019cites this paper
• IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function

  2019cites this paper
• Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome

  2019cites this paper
• p52 expression enhances lung cancer progression

  2018cites this paper
• A panel of noncoding RNAs in non–small‐cell lung cancer

  2018cites this paper
• RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells

  2018cites this paper
• Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets

  2018cites this paper
• The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients

  2018cites this paper
• The prognostic role of the non-canonical NF-kappa B pathway in renal cell carcinoma patients

  2018cites this paper
• The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells

  2018cites this paper
• Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis

  2018cites this paper
• Co‐expression of NF‐κB‐p65 and phosphorylated NF‐κB‐p105 is associated with poor prognosis in surgically resectable non‐small cell lung cancer

  2018cites this paper
• Exopolysaccharides from a Codonopsis pilosula endophyte activate macrophages and inhibit cancer cell proliferation and migration

  2018cites this paper
• A link between RelB expression and tumor progression in laryngeal cancer

  2017cites this paper
• Exploring the Role of IL-1 β /IL-1R in the Pathogenesis of K-ras Exploring the Role of IL-1 /IL-1R in the Pathogenesis of K-ras Mutant Lung Cancer Mutant Lung Cancer

  year unknowncites this paper